Visceral leishmaniasis (VL), a deadly parasitic disease, is a major public health concern
globally. Countries affected by VL have signed the London Declaration on Neglected …

Leishmaniasis is a set of complex and multifaceted syndromes, with different clinical
manifestations, caused by different species of the genus Leishmania spp. that can be …

Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many
different species within the genus Leishmania, is an unfamiliar disease to most North …

Quantitation of the nonlinear heterogeneities in Leishmania parasites, sand fly vectors, and
mammalian host relationships provides insights to better understand leishmanial …

Sustained elimination of Visceral Leishmaniasis (VL) requires the reduction and control of
parasite reservoirs to minimize the transmission of Leishmania donovani infection. A simple …

Background To expedite the development of new oral treatment regimens for visceral
leishmaniasis (VL), there is a need for early markers to evaluate treatment response and …

Topical treatment of cutaneous leishmaniasis has demonstrated appropriate alternative for
reducing toxicity of conventional treatments, improving patients' compliance and reducing …

Background An infected host's Leishmania infantum load in blood is considered to be an
estimate of his or her total parasite burden. Therefore, the measurement of blood parasite …

With the Visceral Leishmaniasis/Kala-azar Elimination Program in South Asia in its
consolidation phase, the focus is mainly on case detection, vector control, and identifying …

Background Cutaneous leishmaniasis (CL) is a neglected disease with a broad spectrum of
clinical manifestations, ranging from small cutaneous nodules to severe mucosal tissue …